Government response to 3 medicines reports

The government accepted the Advisory Council on the Misuse of Drugs’ recommendations that Somapacitan, lonapegsomatropin and somatrogon, and Zuranolone, be controlled under class C of the Misuse of Drugs Act 1971 but that Ganaxolone need not be.